1-3 of 3
Shoaib Al-Zadjali, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms

Murtadha Al-Khabori, MD, Shoaib Al-Zadjali, PhD, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, MD, Mohamed Al Huneini, MD, Naglaa Fawaz, MBBChir, MMSc, PhD, Al Lamki Sulayma, MD, Mahdiya Pir Al Bulushi, MD FRCPC, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi
Journal: Blood
Blood (2019) 134 (Supplement_1): 5383.
https://doi.org/10.1182/blood-2019-128309
Published: 2019
Journal Articles

The Optimal Cut-Off Level for Hemoglobin A2 to Differentiate between Sickle Cell Disease Genotypes

Fayiz Al Shueili, MD, Murtadha K. Al-Khabori, BSc,MD FRCPC, MSc, Salam Al-Kindi, Yasser Wali, MD, Shoaib Al-Zadjali, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2391.
https://doi.org/10.1182/blood-2018-99-118697
Published: 2018
Journal Articles

Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

Murtadha K. Al-Khabori, BSc, MD FRCPC,MSc, Shoaib Al-Zadjali, PhD, Mohamed Al-Rawahi, BSc, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, Mohamed Al Huneini, Al Lamki Sulayma, MD, Mahdiya Al-Belushi, MD, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi
Journal: Blood
Blood (2018) 132 (Supplement 1): 5489.
https://doi.org/10.1182/blood-2018-99-118546
Published: 2018